Sunday, October, 25, 2009
Latest Treatment For Osteoporosis
October 03, 2008
The Food and Drug Administration has approved Reclast for sale on
the U.S. market. Reclast is the first once-a-year treatment for
osteoporosis. It is designed to be given in an annual 15-minute
intravenous treatment to women who have postmenopausal
osteoporosis.
Read more »
Expert & Community Posts
By Lila de Tantillo
,
Health Expert
The Ladies' Home Journal just announced their 2007 Health Breakthrough Award recipients, and they...
Read more »
By Lila de Tantillo
,
Health Expert
Zoledronic acid has received a positive approval recommendation in Europe for use in the treatment...
Read more »
By Lila de Tantillo
,
Health Expert
Zoledronic acid, a once-yearly infusion, has been approved by Health Canada for treatment of...
Read more »
By Lila de Tantillo
,
Health Expert
Wyeth is moving forward with its new drug to combat osteoporosis in post-menopausal women. The FDA...
Read more »
By Neil Gonter, MD
,
Health Expert
For the past few years, most physicians have routinely treated osteoporosis in the same manner. ...
Read more »
Health Guide
...include Fosamax (Alendronate), Actonel, Boniva, Didronel and Skelid and are commonly prescribed as
treatments for osteoporosis and osteopenia in post-menopausal women. Intravenous...
Read more »
Ibandronate (Boniva) approved as first once-a-month pill for both treatment and prevention of osteoporosis.Ibandronate (Boniva) injection approved as the first intravenous...
Read more »
Drug ApprovalIn 2006, the FDA approved rasagiline (Azilect) for treatment of Parkinsons disease (PD). Rasagilineis used either alone or in combination with levodopa. It is taken once a day...
Read more »
...and treated according to recommended guidelines. In one of the studies, only 24% of women were given
treatments for osteoporosis after a fracture. In both studies, the older a woman was the less...
Read more »
FracturesBone density loss from osteoporosis is a major cause of disability and death in the elderly, mostly due to subsequent fractures. The lifetime risk of spinal fracture in women is about one in...
Read more »
Related News
July 10, 2009
(Ivanhoe Newswire) -- Regular bone mineral density monitoring in postmenopausal women may be unnecessary and potentially misleading. Researchers...
Read summary »
June 08, 2009
(Ivanhoe Newswire) -- A drug approved for the treatment of osteoporosis is healing broken bones with stem cells. Since 2002, teriparatide (Forteo)...
Read summary »
November 26, 2008
(Ivanhoe Newswire) -- The millions of Americans who take drugs commonly prescribed to treat osteoporosis could be at risk for irregular heartbeats,...
Read summary »
December 29, 2008
(Ivanhoe Newswire) -- A surprising new discovery in how bones grow may lead to a novel treatment of osteoporosis. Bone growth is controlled in the...
Read summary »
May 09, 2007
(Ivanhoe Newswire) -- Postmenopausal women with osteoporosis may only need one dose of medication per year to reduce the risk of fractures. A new...
Read summary »